February 5, 2018 Critical Path to TB Drug Regimens (CPTR) 2018 Annual Workshop, postponed Critical Path Institute and Bill & Melinda Gates Foundation have decided to postpone the Critical Path to TB Drug Regimens Wor
October 24, 2017 US FDA Awards I-ACT for Children a Grant for Pediatric Medicines and Devices Network
October 9, 2017 Critical Path Innovation Meeting On September 14, 2017, Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium and Electronic Patient-Repor
May 22, 2017 miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers
April 18, 2017 New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need
April 11, 2017 PTC Meets Its Deliverables April 11, 2017 Dear Colleagues, In the fall of 2015 C-Path established the Pediatric Trials Consortium (PTC), with the go
February 20, 2017 C-Path CEO Dr. Martha Brumfield Interviewed for RAPS Regulatory Exchange Member Spotlight